Back to trial detailsIntake questionnaire
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Applying to Columbia University · New York, New York
Answer a few short questions to share with the research team.
0 of 4 answered